The overall cardiometabolic medicine market is projected to reach $150 billion by 2035, according to Morgan Stanley estimates
The exclusion criteria were: severe or chronic skin inflammation, serious inner or chronic diseases, intake of drugs that can possibly interfere with skin reactions, application of pharmaceutical or skin care products with active ingredients until 10 days before testing, allergies or severe side effects after usage of cosmetic products, sunbath or usage of tanning bed during the study period, known cancer, pregnancy or lactation period, taking of medication with potential effect on hair growth
Robust evidence from landmark CVOTs, such as LEADER, SUSTAIN-6, and SELECT has proven GLP-1 agonists serve as essential treatment options for T2DM patients at high cardiovascular risk and indicate their growing applications in HFpEF and non-diabetic patients and cerebrovascular disease
22425704, 82188101 and 31872716 to C.L
We use cookies to enhance your browsing experience and improve the functionality of our website
Oxidative Stress and Cognitive Decline: The Neuroprotective Role of Natural Antioxidants